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We have described briefly the acute destruction of rat skin xenografts after 
injections of their hosts with antisera specifically reactive with graft antigens 
(1). The rat skin had been grafted to mice whose immune responses were sup- 
pressed by removal of the thymus and treatment with rabbit antimouse lym- 
phocyte serum. When these xenografts had healed completely into their beds 
and could be fully expected to survive for one or more additional weeks,  the 
mice were injected with  antirat  serum  that had been prepared in mice or in 
rabbits. Signs of graft damage were evident as early as 10 rain after the injec- 
tion  of  serum,  and  in  most  animals  so  injected  the  grafts  were  completely 
destroyed within  24-48 h.  Studies  in  which fixed  sections of grafts were  ex- 
amined microscopically revealed the early occurrence of edema and infiltration 
of the grafts with polymorphonuclear leukocytes followed by extreme dilata- 
tion and congestion of small vessels,  hemorrhage, and necrosis (2). Both gross 
and microscopic aspects of these reactions were similar to those described for 
Arthus reactions and other forms of immune vasculitis in rabbits and guinea 
pigs  (3,  4).  Reactions of the latter  types have been  the  subject of intensive 
investigation in  recent years,  and  a  good deal  has been learned  of the path- 
ways leading to tissue damage in these reactions (5).  We have looked, there- 
fore, for similar mechanisms in the destruction of skin grafts that is mediated 
by humoral antibodies, and the experiments to be described here were designed 
primarily  to evaluate  the  roles  of granulocytes and  the  plasma  complement 
system, agents which are known to be involved in a variety of lesions that are 
initiated  through immunological reactions. 
Materials and Methods 
Experimental System.--The basic test system has been described in detail (2). Adult mice 
were thymectomized 1-2 wk before receiving grafts of rat ear skin. Rabbit antimouse lympho- 
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cyte serum  (RAMLS) 1 was injected intraperitoneally at  a  dose of 0.25  ml  2  days before 
grafting, on the day of grafting, and on days 2 and 4 after placement of the grafts. About 2 wk 
after transplantation when the grafts were well vascularized and in excellent condition, anti- 
sera or  fractions of  antisera specifically  reactive with graft  antigens were  injected intra- 
venously or  intraperitoneally  (i.p.).  The  grafts were  observed for  signs  of  inflammation 
(edema and hyperemia) and epithelial damage. Rejection was considered complete when no 
viable donor epithelium could be detected macroscopically. 
Animals.--Male  and female rats of the following inbred lines were purchased from Micro- 
biological Associates, Inc., Bethesda, Md., and used as sources of ear skin for grafting: Brown 
Norway, Lewis, and Fischer. The recipients of the grafts were mice of the inbred lines B 10. D2 
new and B10.D2  old purchased from the Jackson Laboratory, Bar Harbor, Maine. These 
two lines are congenic with each other as well as with C57BL/10  Sn  (6).  The only known 
genetic difference between the old and new B 10. D2 lines relates to the alleles carried by them 
at the IIc locus (6). Genes at this locus control the synthesis of the fifth component of comple- 
ment (C5),  and there are currently two alternative or allelic forms of the genes that are de- 
tectable. B10.D2 new is homozygous hcl/hc 1 and has detectable levels of C5 and hemolytic 
complement. B10.D2  old is homozygous hc°/hc  °.  These animals have no detectable  C5  as 
measured by functional or immunochemical tests, and therefore, lack hemolytic complement 
(7). Comparative studies with these congenic lines provide a means of evaluating the role of 
C5 and later-acting components of complement in vivo. Female mice were used exclusively in 
all experiments except those summarized in Table IV B; only males were used in the latter. 
A/J and B6AF1 hybrid female mice were also purchased from the Jackson Laboratory and 
used in the preparation of mouse antirat serum (MARS)  or as graft recipients in the initial 
experiments that  demonstrate the immunosuppressive properties of  RAMLS  and  the de- 
structive properties of antirat sera. 
Antisera.--Rabbit  antirat  serum  (RARS),  RAMLS,  and  MARS were prepared  as  de- 
scribed previously (2).  In each case animals were injected first with lymphoid cells in com- 
plete Freund's adjuvant and subsequently with cells suspended in saline.  The major portion 
of the MARS was prepared in B6AF1 hybrid mice. A smaller amount was prepared in  the 
C5-deficient strains, A/J and B10-D2 old, so that antibody free of C5 could be transferred in 
appropriate experiments. 
Chicken antirat serum (CARS) was prepared in two adult female chickens that had received 
five intravenous injections of cells pooled from rat spleens and lymph nodes. The injections 
consisted of l0  s cells and were given at weekly intervals.  1 wk after the last injection,  the 
chickens were bled and the sera were pooled. 
Rabbit antirat granulocyte serum was kindly provided by Dr. Charles G. Cochrane, Scripps 
Clinic and Research Foundation, La Jolla, Calif., and was prepared as described by Cochrane 
et al.  (8). It had been absorbed in Dr. Cochrane's laboratory with rat plasma, packed erythro- 
cytes, and platelets to yield a reagent with a high degree of specificity for polymorphonuclear 
neutrophils. 
The IgG fraction of RARS was isolated as described previously (2) and was digested with 
pepsin to obtain F(ab')2 fragments according to the method of Nisonoff (9). 
Serology.--Cytotoxic  tests were carried out in vitro using mixtures of cells obtained from 
spleens and lymph nodes. Sera were tested in doubling dilutions using rabbit serum as a source 
of complement and dye exclusion  as a criterion of viability. Details of this procedure are de- 
scribed in reference 10. 
Abbreviations used in this paper:  CARS, chicken antirat serum; COF, cobra venom factor; 
HAGG, heat-aggregated gamma globulin; MARS, mouse antirat serum; NCS, normal chicken 
serum; PMN, polymorphonuclear leukocytes; RAMLS, rabbit antimouse lymphocyte serum; 
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Hemolytic  activity of  mouse  complement was  measured  by a  specially devised micro- 
procedure that allowed us to work with very small volumes of fresh mouse serum and to detect 
low levels of activity after attempts to depress complement activity in vivo. Rabbit erythro- 
cytes at a concentration of 6 X  106/ml were sensitized with an equal volume of mouse (A/Sn) 
antirabbit erythrocyte serum diluted 1:600 in buffered saline. This antiserum was known to 
contain a  relatively high concentration of antibodies that were resistant to treatment with 
2-mercaptoethanol and  that  behaved in  chromatographic and gel  filtration analysis as  7S 
gamma globulins. This type of antibody is known to be essential for the activation of hemo- 
lytic properties of mouse complement (11).  Doubling dilutions of fresh mouse sera were pre- 
pared in microtiter plates in volumes of 0.025 ml. 9 #i of each dilution was transferred to indi- 
vidual wells  of microtest plates (Falcon Plastics, Los Angeles, Calif.), and to each well was 
added 1 #l of sensitized rabbit ceils. The mixtures were incubated at 37°C for 45 min, and the 
plates were observed under the microscope. Where complete lysis had taken place, there were 
no cells visible. The end point, which occurred sharply, was taken as the dilution at which 
approximately 50% of the cells were visible. 
Heat-aggregated gamma globulin (HAGG) was prepared from a commercial preparation of 
human globulin (Hyland Div., Travenal Laboratories, Inc., Costa Mesa, Calif.). The protein 
was separated from the glycine stabilizer by gel filtration (Sephadex G-50) and heated for 20 
min at 63°C in a water bath. The final concentration of protein was 100 mg/ml. 
The purified fraction of cobra venom used for inhibition of complement in vivo was kindly 
supplied  by Dr.  R.  A. Prendergast, Department of Microbiology, Johns Hopkins School of 
Medicine, Baltimore, Md. It had been prepared from crude venom according to the procedure 
described by Ballow and Cochrane (12). 
The nitrogen mustard used to depress polymorphonuclear leukocytes (PMN) in vivo was 
Mustargen (Merck, Sharpe & Dohme, West Point, Pa.). 
RESULTS 
Rat skin grafted onto untreated mice healed into place and behaved essen- 
tially as do allografts of mouse skin. However, the xenografts provoked more 
intense responses than do allografts and were, accordingly, rejected at an earlier 
time than the former. The median survival time for grafts placed on 39 mice 
was 7.8 days. When the recipients had been thymectomized and treated with 
RAMLS, the rat skin survived for much longer periods of time, in some cases 
for up to 3 too. The median survival time for grafts on 79 treated animals was 
31.6 days (Fig. 1). The data presented in this figure come from a series of ex- 
periments in which several lots of RAMLS of varying potency were employed, 
but there was in every case marked prolongation of graft survival on treated 
mice. When B10.D2  (new) mice that were bearing completely healthy grafts 
on day 14 were injected with MARS, intense inflammatory responses developed 
in the grafts of all of the injected animals within 1-3 h, and at 24 h  there was 
frank necrosis in all but  1 of 36 grafts.  This single graft recovered from the 
early inflammatory process and was later rejected through  the action of the 
host's own immune responses. Four grafts were completely destroyed by 24 h, 
and in the remainder there were varying degrees of epithelial damage ranging 
upward from 25%. Most of these latter grafts deteriorated rapidly, and 80% 
of all of the grafts in this experimental group were totally destroyed at 72 h. 
The remaining six grafts had, at this time, areas of viable epithelium amount- 896  DESTRUCTION  OF  SKIN  GRAFTS  BY  HUMORAL  ANTIBODY 
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FIG. 1. The effect of MARS on rat skin grafted onto mice whose immune responses have 
been suppressed by thymectomy  and treatment with rabbit antilymphocyte serum (ALS). 
Numbers in parentheses indicate the numbers of mice in each group. 
ing to  10-50%  of  that  of  the  original grafts.  Three of  these reached  a  state 
of  total destruction within the  next 24  h  while  the  others  maintained some 
viable epidermis for  several  days,  complete  destruction  probably  being  at- 
tained in part as the result of active host responses to graft antigens. 
The process of graft rejection as it occurs in mice of all of these experimental 
groups has been studied microscopically, and the results of  these  studies are 
reported elsewhere (2). The work described here is based on gross observations 
of the grafts, and as can be seen from Fig. 2, the effects of MARS are striking 
indeed and easily detected. 
That the variations observed in grafts  in response to  injections of  MARS 
are not attributable to the use of marginal doses of antiserum can be seen from 
the  results  of  experiments in which  injected mice were  bled  and  their  sera 
tested for residual activity in vivo and in vitro. These experiments were de- 
signed to show also that MARS was present in recipients in excess of that re- 
FIG. 2.  (a) A Lewis rat ear skin graft surviving in perfect condition on a  thymectomized, 
ALS-treated mouse at 14 days. Ear skin is normally less pigmented than skin from the body 
wall and has fewer hair follicles. (b) This photograph shows the acute changes produced in the 
same graft as in (a) 48 h after its recipient had received 0.S ml of a mouse antirat serum intra- 
peritoneally. Darker zones represent advanced necrosis in the inflamed and edematous graft. 
Changes of almost as severe a degree were present in this graft at 24 h. X 10-1l. 898  DESTRUCTION  OF  SKIN  GRA]~TS  BY  HUMORAL ANTIBODY 
quired for graft destruction  so that the availability  of antibody would not be 
a  limiting  factor in  the  studies  on the  roles of PMN  and  complement in  the 
destructive process. 
Eight mice bearing rat skin were injected i.p. with  1.0 ml of MARS that had 
a cytotoxic titer of 1 : 1024. 24 h  later, when all of the grafts had been destroyed, 
the  mice  were  bled  and  the  sera  from  individual  bleedings  were  tested  for 
cytotoxic activity.  Five  of the  sera  had  titers  of  1:256,  the  other  three  had 
titers  of 1:512. All of the sera were pooled and injected i.p.  at a dose of 2 ml 
into  two  additional  mice that had been  grafted  with  rat  skin.  The following 
day both of the grafts were necrotic, and the sera of both animals were found 
to have cytotoxic titers of 1 : 128. It seems unlikely that any of our experimental 
results can be attributed  to limiting  amounts of antibody. 
The  involvement  of complement  in  the  destruction  of  rat  skin  xenografts 
that  follows  the  injection  of  their  hosts  with  antiserum  was  investigated 
through  the  use  of  (a)  non-C-fixing  antibodies  or  antibody  fragments,  (b) 
agents  capable  of depleting  complement  components  transiently  in vivo, and 
(c) mouse strains with genetically determined deficiencies of C5. 
Properties of F(ab')2 Fragments Prepared from RARS.--The immunoglobulin 
fragments obtained by pepsin digestion of an IgG preparation were concentrated 
to the volume of serum that served as starting material,  and they were tested 
for specific toxicity and specific inhibitory properties in vitro and in vivo. 
In tests  carried  out in vitro  the F(ab')2 fragments were found to have low 
levels of C-dependent  toxicity for rat  lymphocytes (Table  I).  This  might be 
attributed  to the presence of undigested molecules in the preparation,  but the 
ability  of  this  material  even when  diluted  over  100-fold  to inhibit  the  cyto- 
toxicity of RARS from which it was derived argues against this interpretation. 
It  seems  more  likely  that  F(ab')2  obtained  by pepsin  digestion  retains  some 
ability  to  activate  rabbit  C,  and  this  activity  is  detectable  only when  high 
concentrations of the fragments are employed. 
TABLE I 
Inhibition of the Cytotoxic Properties of MARS and RARS by F(ab')2 Prepared  from RARS* 
Dilution of F(ab')2~* 
Cytotoxic  titer 
MARS  RARS 
--  1:1024  1:512 
1:40  1:4  1:4 
1:80  1:4  1:4 
1:160  1:64  1:32 
* F(ab')2  fragments  were prepared  by pepsin digestion of IgG and reconstituted  to the 
volume of serum from which the IgG was prepared.  This preparation  had a C-dependent 
cytotoxic titer of 1:16. 
:~ Rat lymphoid ceils were incubated with F(ab%_ for 30 min at 37°C, washed twice with 
balanced salt solution, and then tested  with MARS and RARS and rabbit  C. WINN,  BALDAMUS~ JOOSTE~  AND  RUSSELL  899 
In  the  inhibitory tests  carried out with  F(ab')~  derived from RARS,  the 
rat lymphoid cells were incubated with fragments and washed before incuba- 
tion with dilutions of antirat serum and C. In these circumstances the cyto- 
toxic properties of MARS were also blocked by the F(ab')2 (Table I). 
When the fragments were injected into mice that had been grafted with rat 
skin,  signs  of mild  inflammatory processes were seen  in  some of the grafts, 
but these invariably subsided and  the grafts were actively rejected by their 
hosts more than a week later (Table II). If mice bearing rat skin grafts were 
injected with  F(ab')2 and  then 24 h  later with IgG  (RARS)  or MARS,  the 
grafts were unaffected by the second injections that, as seen in control animals, 
could be expected to induce inflammation in all of the grafts and to cause de- 
struction of most of them. 
TABLE  II 
The Effect of CARS or F(ab')2 from RARS on  Xenografls  of Rat Skin 
no.  of grafts showing 
no.  of mice  inflammation 
no.  of grafts  Treatment i.p.  (BI0- D2  destroyed§ 
Mild and  new)  Severe*  transient:~ 
lm/ 
IgG (RARS)  2  2  --  2 
F(ab')2  (RARS)  6  0  2  0 
F(ab') 2 (RARS) I]  0  2  0 
+  2 
IgG (RARS)  0  0  0 
MARS  12  12  --  10 
F(ab')2  (RARS) H  0  9  0 
+  12 
MARS  0  0  0 
CARS  14  0  0  0 
NCSll 
+  5  5  0  5 
MARS 
CARSI[ 
+  11  0  1  0 
MARS 
* Edema  and  erythema  appeared  within  1-2  h  after  administration  of  serum  and  in- 
creased in intensity for 4--6 h  at which time there was evidence of interstitial hemorrhage. 
In all but two cases this was followed by necrosis and sloughing. 
:~ Mild  edema and erythema appeared  at 4--8 h  after administration of serum but were 
no longer detectable  at  12  h. There was no hemorrbage or necrosis. 
§ No viable epithelium detectable 24-48 h  after administration of serum. 
I] CARS, normal CS or F(ab')2  from RARS was injected,  and the grafts were inspected 
periodically  for  24  h  after which the second material was injected.  In the case of normal 
chicken serum (NCS)  and CARS no reactions were observed during the first 24 h. 900  DESTRUCTION OF  SKIN  GRAFTS BY  I-IUMORAL ANTIBODY 
The Effect  of Chicken  Antirat  Serum  on Rat Skin  Xenografts.--Antibodies 
produced in avian species interact poorly or not at all with complement com- 
ponents  of mammalian plasma (13).  CARS  might,  therefore, be expected  to 
behave in our test system as did F(ab')2 fragments prepared from RARS.  In 
tests carried  out in vitro,  CARS was not  toxic for rat lymphoid cells in  the 
presence of rabbit C, guinea pig C, or mouse C. Furthermore, when rat lym- 
phocytes were  incubated  with  CARS  for  30  rain  at  37°C  and  then  washed 
twice with balanced  salt solution  and  tested  with  MARS  and  rabbit  C,  the 
cytotoxicity of the latter reagents was markedly inhibited  (Fig. 3). 
After injections of CARS into mice bearing rat skin grafts, no signs of in- 
flammation were  detected  in  the  grafts  that  survived for  the  same periods 
of time as grafts on uninjected mice (Table II). If the injections of CARS were 
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FIG. 3.  Inhibition of the C-dependent cytotoxic activity of MARS by CARS. 
followed by the administration of MARS 24 h later, the grafts were not damaged 
by the latter. In mice injected with normal chicken serum first and with MARS 
at 24 h, all of the grafts were destroyed 1-2 days later. Thus CARS that failed 
to activate mouse C in vitro not only fails to cause damage to the skin grafts 
in vivo but also blocks the action of MARS and is presumed, therefore, to have 
combined with graft antigens. 
Destruction of Grafts on Hosts Depleted  of Complement Components.--Initially, 
attempts to deplete mice of complement components were made by injecting 
the  animals i.p. with HAGG. With  this form of treatment it was difficult to 
reduce hemolytic activity of serum to less than 15-20% of control values, and 
it was not possible to maintain low levels for more than  12-15  h  without in- 
ducing toxicity. By injecting 50 mg i  h before and 4 h after the administration 
of MARS, we were able to reduce the level of C sufficiently to interfere with graft 
destruction  without  inducing  any  obvious  side  effects.  In  mice  so  treated 
there was a delay in the appearance of inflammation, and complete destruction WIN-N, BALDAMUS~ JOOSTE~  AND  RUSSELL  901 
of the grafts, which occurred in four out of six animals, was not observed until 
days 3-5  after treatment with MARS (Table III). Since C  levels had risen to 
50%  of control values by 24 h  and were essentially normal at 36 h,  it is not 
surprising that these reactions were delayed rather than completely inhibited. 
Table III also contains results of experiments in which mice were depleted 
of  complement  components  by  the  injection  cobra  venom  factor  (CoF),  a 
reagent which proved to be far more efficient than HAGG in preventing damage 
to skin grafts after administration of MARS. The effect of CoF, given in various 
doses, on the hemolytic activity of mouse C is shown in Fig. 4. The mice used in 
this experiment were normal B10.D2  new females,  and  the CoF preparation 
TABLE III 
Antiserum-Mediated  Destruction  of Grafts in Mice Treated  with HAGG or CoF 
Treatment: 1.0 ml MARS  (i.p.)  + 
no. of  First signs of 
mice  inflammation  Rejection*  (days) 
(B10.D2 
new)  <1 h  1-3 h  3-12  h  1  2  3-6 
Recovery:~ 
--  I1  9  2  --  7  2 
HAGG§  6  --  3  3 
CoF (0.1 ml) 1 h before MARS  8  1  3  4  4  1 
CoF (0.3 ml) 1 h before MARS  8  --  2  6  6  1 
CoF 
0.3 ml 1 h before MARS  4  --  --  4 
0.1 ml 18 h after MARS 
--  2 
4  2 
2  1 
1 
* Rejection was taken as the point at which viable epithelium was no longer detected on 
gross inspection. 
~: These grafts showed signs of inflammation of varying degrees of intensity after the in- 
jection of MARS, but they recovered  fully normal appearances and were actively rejected 
2-3 wk later. 
§ 50 mg of heat-aggregated human gamma globulin was injected i.p. 1 h  before and 4 h 
after MARS. 
contained  1.2  mg  protein/ml.  Hemolytic  C  was  completely suppressed  1  h 
after the injection of 0.05 ml but was at essentially normal levels within 48 h. 
A  dose of 0.3 ml suppressed all hemolytic activity of serum for at least 24 h, 
and at 48 h  there was about 30 %  recovery. Mice bearing skin grafts were in- 
jected with either 0.1 or 0.3 ml 1 h  before receiving MARS. There was a delay 
in the appearance of inflammation in all of the grafts, but the pattern of de- 
struction of these grafts was essentially the same as that seen in control mice 
(Table III). Four mice were injected with 0.3 ml of CoF 1 h  before MARS was 
given and again with 0.1 ml 18 h  after the antiserum had been injected. Signs 
of inflammation appeared in  all of the grafts, but  the reactions were  late in 
developing and were milder than  those seen in control mice. Furthermore,  all 
of these grafts recovered and were  actively rejected 2-3  wk later. Thus  CoF 
can  interfere with  the  chain  of reactions initiated by MARS  and  leading to 902  DESTRUCTION  OF  SKIN  GRAFTS  BY  HUMORAL  ANTIBODY 
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FIG. 4.  Inhibition of the hemolytic activity of mouse C after the injection of CoF. 
graft  destruction,  but  the  amounts  required  for  complete protection  of  the 
grafts were higher than might be anticipated on the basis of the measurements 
of hemolytic C. This is probably due to a requirement for higher concentrations 
of C3 for hemolysis than for the C-dependent reactions involved in graft dam- 
age.  Since the role of C  seems to lie in  its ability to attract  leukocytes  and 
since very low levels of PMN suffice to cause graft damage (see below),  this 
explanation seems plausible. 
Antibody-Mediated Destruction of Rat Skin Grafted onto C5-Deficient Mice.- 
The importance of  C5  in  antiserum-mediated destruction  of skin  grafts was 
studied  by comparing the effects of MARS  on grafts placed  on B10.D2  new 
(C5+)  and  B10.D2  old  (C5-)  mice. Antiserum  was  administered  in  doses 
ranging from 1.0  to 0.05  ml in the case of B10.D2 new mice and from 1.0  to 
0.1  ml in B10. D2 old animals. The results of this experiment are presented in 
Table IV A. At a dose of 1.0 ml there were inflammatory processes in all of the 
grafts of both lines of mice, but there were important differences in their overall 
responses to this treatment. In C5(-t-) recipients signs of inflammation appeared 
earlier and hemorrhage and necrosis were more commonly observed; all but 1 
of 26 grafts were completely destroyed by 3 days and 16 of these had no viable 
epithelium at 24 h. In C5(--) mice 12 of 20 grafts were destroyed by treatment 
with antiserum; one of these was sloughed on day 2 and the other 11 on days 4 
and 5 after treatment with MARS. 
At lower doses of MARS the differences in the responses of the two strains 
of mice were even more striking. Only 1 of 12 grafts on C5(--) mice injected 
with 0.1-0.5 ml of serum was destroyed; whereas, all of the 13 grafts on C5(-}-) 
mice  treated  with  similar  doses  were  destroyed,  and  3  of  5  grafts  on  mice 
treated with 0.05 ml of MARS were also destroyed. Thus a far greater quantity 
of antiserum is required to cause graft destruction in B10. D2 old mice, and the 
tempo of the destructive process is consistently slower in these recipients than 
in B10.D2 new mice. WINN~  BALDAMUS,  JOOSTE~ AND  RUSSELL  903 
TABLE  IV A 
Thelnflu~ce ~  C5onthePattern  ~  Antlserum-MMiat~ Destruction ~  RatSkinGraft* 
No. of  First signs of inflammation  Rejection  (days)~:  No 
mice  C5  MARS  Recovery§  reaction  <1 h  1-3 h  3-12 h  1  2  3-,5 
ml 
26  +  1.0  20  5  1  16  7  2  1 
6  +  0.5  6  --  --  1  4  1  -- 
7  +  0.1  6  1  --  1  5  1  -- 
5  +  0.05  3  2  --  1  1  1  2 
20]1  --  1.0  1  5  14  --  1  11  8  -- 
3  --  0.5  --  1  2  --  --  1  2  -- 
5  --  0.25  --  --  5  --  5  -- 
4  --  0.1  --  --  1  --  1  3 
* Rat skin was grafted to female mice of the strains B10.D2 new (C5+)  or B10-D2 old 
(C5-)  and MARS was injected i.p. at the doses indicated. 
;~ Rejection was taken as the point at which viable epithelium was no longer detected on 
gross inspection. 
§ These grafts showed signs of inflammation of varying degrees of intensity after the in- 
jection of MARS,  but they recovered fully normal appearances and were actively rejected 
2-5 wk later. 
[] One-half of the mice in each of these two groups received MARS  that had been pre- 
pared in A/J or B10.D2  old mice so that no C5 was introduced with the antibody, There 
were no differences in the reaction of mice receiving either type of MARS. 
The  C5  is  responsible for  these differences  can be seen  from  the  results  of 
experiments  in which fresh  serum  from  C5(+)  mice  was  injected in B10.D2 
old graft recipients along with MARS  (Table IV B). In five mice treated with 
0.4  ml  of  fresh  normal  serum  mixed  with  only  0.1  ml  of  MARS,  the  grafts 
showed  early,  intense  inflammation,  and  four  of  the  grafts  were  completely 
destroyed  within 48  h.  The  remaining graft had  about  50%  of  its epithelium 
destroyed  at this time, but  the rest of the graft was not damaged  until several 
days  later when many  of the control  grafts were  being actively rejected.  The 
activity of the fresh normal serum was destroyed when it was heated  to 56°C 
for 30 rain. 
The  results  of  this  last  experiment  might  be  construed  to  mean  that  the 
data presented in Table IV A  come from responses to variations in the dose of 
C5 contained in the MARS  and that in the absence of C5 no tissue damage can 
occur. However,  as indicated in Table IV A, half of the mice that were injected 
with  1.0 ml of  MARS  received  serum  that  had been prepared  in  CS-deficient 
animals,  and  the  reactions  observed  in  their  grafts  were  not  distinguishable 
from those observed in grafts on mice injected with MARS  prepared in B6AF1 
mice.  Furthermore  in a  study  of MARS  prepared  in various inbred strains of 904  DESTRUCTION  OF  SKIN  GRAFTS  BY  HUMORAL ANTIBODY 
TABLE IV B 
The Influence of C5 on the Pattern of Antiserum-Mediated Destruction of Rat Skin  Grafts* 
First signs of inflam-  Rejection (days)§ 
No. of  marion  mice  MARS** (0.1 ml) +  Recoveryl[ 
< 1 h  1-3 h  3-12  h  1  2  3-5 
5  0.4 ml saline  0  2  3  5 
5  0,4 ml C5+ serum  0  4  i  0  1  3  I 
5  0.4 ml C5+ serum (heated 56°C  0  2  3  5 
for 30 min) 
* Rat skin was grafted to B10.D2 old male mice that lack C5. 
:~ All of the mice were injected i.p. with a mixture containing 0.1 ml of MARS and 0.4 
ml of saline or normal mouse serum as indicated. 
§ Rejection was taken as the point at which viable epithelium was no longer detected on 
gross inspection. 
][ These grafts showed signs of inflammation  of varying degrees of intensity after the in- 
jection of MARS, but they recoveied fully normal appearances and were actively rejected 
2-7 wk later. 
mice the ability of C5-deficient antisera to mediate graft destruction in C5(-) 
recipients was observed in large numbers of mice3 
The survival time of rat skin grafted onto nonsuppressed mice lacking C5 was 
the same as that for grafts placed on C5+  animals, and no significant differences 
were seen in the survival times of grafts placed on mice of these two sublines 
when their immune responses were suppressed by thymectomy and treatment 
with RAMLS. 
The Role of PMN  in Antiserum-Mediated  Destruction  of Skin  Grafts,--The 
numbers of circulating PMN  in mice bearing rat skin grafts were decreased by 
treatment with nitrogen mustard  or by the  administration  of  rabbit  antirat 
PMN  serum.  The  action of nitrogen mustard is far less specific than  that of 
antiserum, and it was found difficult with this reagent to maintain the counts 
of  circulating PMN  at low  levels without  causing  toxic side effects in  mice. 
However, a  regimen of 0.05  mg of Mustargen given 3 days before MARS and 
0.025 mg given 1 day before MARS resulted in a  reduction in PMN  counts to 
40-80  cells/ram  3 at  the time of administration of the antiserum,  without  in- 
ducing untoward reactions and without lowering the levels of hemolytic C. In 
mice  so treated  the  MARS had little influence on  the fate of the skin grafts 
(Table V). In one of seven recipients there was late and transient inflammation 
in the graft; no effects were observed in the grafts on the other six mice. 
Two mice that had received rat skin grafts were treated with rabbit antirat 
PMN  serum at a  dose of 0.3  ml on days 3,  2,  and  I  before administration of 
MARS.  The  numbers  of PMN  in  the peripheral blood of these  two  animals 
were  220  and  230/mm3;  platelet counts and  C  levels were normal. There was 
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TABLE  V 
The Role of •MN  in Antlserum-Mediated Destruction of Rat Skin Grafted onto Mice 
Treatment: 1.0  No. of mice  Inflammation 
ml MARS  (B10- D2  Total WBC/mm  3  PMN/mm  3  Rejec-  Recov- 
+  new)  <3 h  5-24  h  None  tion*  ery$ 
--  11  1.5-2.0  X  104  4-5  X  103  9  2  0  9  2 
N-mustard§  7  1-2 X 103  40-80  --  1  7  --  1 
Anti-PMNll  2  2.2  X 104  220-230  --  1  1  --  1 
serum 
* Rejection,  taken  as  the  point  at  which  viable  epithelium was  no  longer  detected  on 
gross inspection, occurred 2448 h  after administration of MARS in these mice. 
:~ These grafts showed signs of inflammation of varying degrees of intensity after the in- 
jections of MARS,  but they recovered fully normal appearances and were actively rejected 
2-3 wk later. 
§ 0.05 mg 3  days before MARS and 0.025 mg 1 day before MARS. 
II 0.3 ml rabbit antirat PMN serum on days 3, 2, and 1 before MARS. 
mild inflammation in one graft at 8-12 h after the injection of MARS, but this 
resolved and the graft was actively rejected several days later. The graft on the 
other animal showed no effect of the antiserum injection and was not rejected 
for several weeks. PMN seem, therefore, to be essential for the development of 
early inflammatory processes as well as for the destruction of the grafts after 
the injection of MARS. 
DISCUSSION 
The process of tissue destruction that we have described here is, undoubtedly, 
the outcome of a complex series of events that are initiated by the combination 
of antibodies with graft antigens and that involve the generation of a variety 
of substances that affect the tone of small blood vessels and the integrity of 
their walls. These substances are in many instances the end products of multi- 
stepped, sequential reactions, and they interact among themselves in ways that 
are not well understood. Our data shed no light on the nature or direct mode of 
action  of these  effector substances,  but  they do  show  that  complement and 
polymorphonuclear leukocytes play essential roles in  the development or ex- 
pression of them. 
With respect to complement, our data provide several lines of evidence that 
some components are essential for the production of graft damage that follows 
the  injection  of antibodies.  Neither  CARS  nor F(ab')e derived  from RARS 
serve as efficient activators of mouse C, and neither caused destruction of grafts 
though it could be inferred from their inhibitory properties in vivo that they 
had  combined with  graft antigens.  Secondly,  depletion  of complement com- 
ponents  in  vivo with  CoF  or heat-aggregated  gamma globulin  prevented  or 
delayed the occurrence of tissue destruction that routinely follows the injection 
of MARS. Lastly, our experiments with C5-deficient mice implicate components 906  DESTRUCTION  OF  SKIN  GRAFTS  BY  HUNIORAL  ANTIBODY 
of C as mediators of graft damage and help also to clarify the roles of some in- 
dividual components in this process. Rat skin grafted onto either B10.D2 new 
(C5+) or B10. D2 old (C5--) mice was destroyed by injections of MARS, but 
in the case of the former strain the process was initiated much sooner, it de- 
veloped more rapidly, and re@red less antibody. While C5 is not essential for 
the production of tissue damage in this process, it, or some components that act 
later in  the complement sequence,  can obviously contribute  to the tissue de- 
struction, and in a more efficient way than earlier acting components. 
That antiserum can cause destruction of grafts in the absence of C5  shows 
that direct lysis of graft cells by C is not essential in this process. Indeed,  C- 
mediated lysis does not seem to occur to an appreciable extent even in B10-D2 
new mice since tissue damage was not detected when C levels were normal, but 
the numbers of PMN were greatly reduced.  The requirement for PMN sug- 
gests that the role of C is to bring the leukocytes to the sites at which antibodies 
have become bound  to antigens in the graft. This is an attractive suggestion 
since it fits well with all of our observations as well as with known properties 
of chemotactic substances derived from C. There are at least two stages in the 
sequence  of C  reactions  at which  substances  chemotactic for PMN  are gen- 
erated. After the reaction of C3 with  C142  there appears a  derivative of C3, 
probably C3a, that has been shown to attract PMN in vitro (14). Further on 
in the sequence the reaction of C5 with C1423 is followed by the appearance of 
a  powerful chemotactic substance,  the  composition of which  is not precisely 
known. It has been claimed that the activity resides in a split product of C5, 
(C5a), as well as in a trimolecular complex C567 (15, 16).  In either case there 
is agreement on the importance of C5, and in a recent study it has been shown 
that mice lacking C5 do not mobilize PMN in response to inflammatory stimuli 
involving C nearly as efficiently as C5+ mice do (17). The difference between 
the  responses of the  two types of animals was  especially marked during  the 
first 24  h  after application of the  stimuli.  These observations are  consistent 
with the demonstration that the chemotactic activity of substances containing 
or derived from C5 is much greater than that of C3 derivatives (18). 
On  the basis of this discussion we can offer a plausible construction  of the 
events leading up to damage of the skin grafts in our experimental system. Anti- 
bodies react with antigens in the graft, probably those present on the surface 
of vascular endothelial cells.  These immune complexes activate C1 initiating a 
series of events the precise nature of which depends on the availability of in- 
dividual  components of the  complement system and  the  level  of circulating 
PMN as well as other factors not directly implicated in the present study but 
known to be of importance in the production of tissue damage by immune re- 
actions. In mice with normally functioning components of C, chemotactic sub- 
stances are generated from both C3 and C5, and PMN are rapidly brought into 
the vascular bed of the graft that becomes the site of an intense inflammatory 
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PMN as well as of a variety of substances that appear at sites of inflammation. 
In mice that lack C5 the attraction of PMN into the graft depends largely on 
the action of C3a, though immune adherence may also participate in this proc- 
ess.  Cells are mobilized slowly; the inflammatory process develops only gradu- 
ally and often subsides before significant tissue damage occurs. CoF depletes 
animals  of C3  and later-acting components thus impeding  the generation of 
chemotactic agents and preventing damage to the graft at least until the levels 
of relevant components are restored. It is not clear which components of C are 
depleted after injections of aggregated gamma globulin, but it can be inferred 
that the development of chemotactic factors is retarded and that damage to 
grafts in mice treated first with HAGG and  then with MARS  is delayed or 
absent. 
The participation of polymorphonudear leukocytes in the type of graft de- 
struction described here was initially suggested by the results of microscopic 
studies of fixed tissues (1). The essential role of these cells in the process is in- 
dicated in the present study by the results of experiments in which either ni- 
trogen mustard or specific antiserum was used to depress the numbers of circu- 
lating PMN. When the numbers of the cells were brought to very low levels, 
tissue damage was prevented even though C was present in normal concentra- 
tions. The destruction of vascularized grafts of skin by humoral antibodies is 
thus an additional example of immune damage to tissues in which PMN seem 
to be of central importance. 
The mechanisms through which leukocytes cause destruction of the grafts 
are not illuminated by the results of our present studies, but it seems reasonable 
to suppose that they are similar to those involved in Arthus reactions and other 
forms of vasculitis and immune damage triggered by the combination of anti- 
gens with antibodies in vivo (19). Further experimentation obviously will be 
needed to clarify this matter. 
We have emphasized the importance of antigens on endothelial cells for two 
reasons.  First,  the  time  that  lapses  between  intravenous  administration  of 
antiserum and the earliest signs  of inflammation in the graft is often less than 
10 min. It seems unlikely that antibody could have left the vascular bed and 
triggered an inflammatory response in this short period of time. Secondly, our 
microscope observations suggest that vascular breakdown followed by hemor- 
rhage  and  thrombosis  precedes  and  probably  accounts  for damage  to  non- 
vascular elements of the grafts. Indeed, high concentrations of antibody may 
reach the latter only when the vasculature is badly damaged.  That we have 
seen intense edema in some grafts that were not destroyed after administration 
of antiserum shows that when antibodies do have access to cells lying outside 
the blood vessels, they do not always cause detectable damage to the graft; but 
this  issue  can  probably be  resolved  only through  the  use  of grafts  of pure 
epidermal cells. 
While essential roles for C and PMN have been established for the destruc- 908  DESTRUCTION  OF  SKLN  GI~FTS  BY  ItU~cIORAL ANTIBODY 
tion of skin grafts by antisera in our experimental system, it seems unlikely 
that they will turn out to be the only factors whose participation is obligatory, 
and there will almost certainly be ancillary substances that contribute to the 
development of the inflammatory process accompanying destruction but that 
may not be indispensable to the overall reaction. It should be possible, through 
further studies, to delineate the roles of all of these effector substances and to 
provide a  clearer picture of the ways in which humoral  antibodies can bring 
about the destruction of vascularized grafts. 
SUMMARY 
A study has been made of the roles played by complement and polymorpho- 
nuclear leukocytes (PMN)  in  the acute destruction of xenografts of rat skin 
that  follows injection of  their  hosts  with  antisera  specifically reactive with 
graft antigens.  The rat skin was grafted onto mice whose  immune responses 
were suppressed by removal of the  thymus  and  a  brief course of treatment 
with rabbit  antimouse lymphocyte  serum.  At about  2 wk  after grafting the 
mice  were  injected  intravenously  or  intraperitoneally  with  mouse  antirat 
serum (MARS). This time interval was chosen because it avoided the compli- 
cations that might be associated with either the process of healing in or with 
incipient  rejection.  Signs  of graft damage  were  evident  as  early  as  10  min 
after the injection of MARS, and in most animals  so injected the grafts were 
completely destroyed within 24-48 h. 
The role of complement (C)  in  this  acute destructive process is indicated 
by the  results of three lines of experimentation.  (a)  Non-C-fixing antibodies 
or  antibody  fragments  failed  to  cause  damage  to  the  grafts.  Indeed,  both 
chicken antirat serum and F(abQ2 fragments from rabbit antirat serum com- 
pletely protected the grafts  against  the  effects of MARS  that was  adminis- 
tered 24 h  later.  (b)  When mice were depleted of hemolytic C  by treatment 
with  cobra  venom  factor  or  heat-aggregated  gamma  globulin,  the  damage 
caused  by MARS  was  greatly reduced or  completely inhibited.  (c)  In  mice 
with a genetically determined absence of C5 much greater quantities of MARS 
were required to cause graft damage; the tempo of the destructive process was 
consistently slower; and a greater number of grafts recovered from the initial 
inflammatory process than was  the  case for animals  with  an intact  comple- 
ment system. 
The  participation  of  PMN  in  serum-mediated  destruction  of  grafts  was 
initially suggested  by the results of microscope examination of fixed tissues. 
The essential  role of these  cells  in the process is indicated by the failure of 
MARS  to  cause  tissue  damage  in  mice  whose  circulating  PMN  have  been 
reduced to very low levels by treatment with nitrogen mustard or more spe- 
cifically with an anti-PMN serum. 
The absence  of tissue  damage  when  circulating PMN  are  reduced but  C WINN~ BALDAMUS, JOOSTE~ AND RUSSELL  909 
levels  are normal  suggests  that  C-mediated  cytolysis is unimportant  in graft 
destruction  and  that  the role of C  lies in its  ability  to generate  chemotactic 
factors. The latter may then attract the PMN that provide mediators of tissue 
damage. 
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